Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1985 4
1986 2
1987 3
1989 4
1990 3
1992 1
1994 1
1998 1
2002 2
2003 2
2004 1
2005 1
2006 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Short contact therapy with tazarotene in psoriasis vulgaris.
Veraldi S, Caputo R, Pacifico A, Peris K, Soda R, Chimenti S. Veraldi S, et al. Dermatology. 2006;212(3):235-7. doi: 10.1159/000091250. Dermatology. 2006. PMID: 16549919 Clinical Trial.
BACKGROUND: We present the results of a multicentre, not controlled, clinical study on the tolerability and efficacy of tazarotene gel, used as short contact therapy (SCT), in psoriasis vulgaris. OBJECTIVE: To evaluate whether irritant contact d …
BACKGROUND: We present the results of a multicentre, not controlled, clinical study on the tolerability and efficacy of tazarotene gel, used …
Efficacy of short-contact therapy with dithranol in childhood psoriasis.
Zvulunov A, Anisfeld A, Metzker A. Zvulunov A, et al. Int J Dermatol. 1994 Nov;33(11):808-10. doi: 10.1111/j.1365-4362.1994.tb01005.x. Int J Dermatol. 1994. PMID: 7822090
METHODS: The efficacy of short-contact therapy, a dithranol cream preparation, was retrospectively evaluated in 58 children with psoriasis. ...Mild adverse skin reactions occurred in 20% of patients, but only one patient had to discontinue therapy
METHODS: The efficacy of short-contact therapy, a dithranol cream preparation, was retrospectively evaluated in 58 chil …
Comparison of dithranol and butantrone in short contact therapy of psoriasis.
Göransson A. Göransson A. Acta Derm Venereol. 1987;67(2):149-53. Acta Derm Venereol. 1987. PMID: 2438880 Clinical Trial.
Thirty psoriatic out-patients were treated as a right-left comparison with dithranol (0.1, 0.5, 1, 2%) and butantrone (0.66, 1.3, 2.7, 3.9%) short contact therapy, both in white petrolatum. ...Six patients showed some improvement, but in four of them the dith …
Thirty psoriatic out-patients were treated as a right-left comparison with dithranol (0.1, 0.5, 1, 2%) and butantrone (0.66, 1.3, 2.7, 3.9%) …
Short-contact therapy with tazarotene in psoriasis vulgaris.
Veraldi S, Schianchi R. Veraldi S, et al. Dermatology. 2003;206(4):347-8. doi: 10.1159/000069953. Dermatology. 2003. PMID: 12771482 No abstract available.
Development of anthralin short-contact therapy in psoriasis: survey of published clinical trials.
Naldi L, Carrel CF, Parazzini F, D'Oro LC, Cainelli T. Naldi L, et al. Int J Dermatol. 1992 Feb;31(2):126-30. doi: 10.1111/j.1365-4362.1992.tb03254.x. Int J Dermatol. 1992. PMID: 1532790
In a survey of clinical trials concerning the efficacy of short-contact therapy with anthralin in psoriasis vulgaris, focusing principally on methodologic issues, twenty-four papers published between January 1982 and December 1989, in English, French, …
In a survey of clinical trials concerning the efficacy of short-contact therapy with anthralin in psoriasis vulg …
Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. Modifications of short-contact therapy and Ingram therapy.
Schulze HJ, Schauder S, Mahrle G, Steigleder GK. Schulze HJ, et al. J Am Acad Dermatol. 1987 Jul;17(1):19-24. doi: 10.1016/s0190-9622(87)70165-0. J Am Acad Dermatol. 1987. PMID: 3611453
In 44 patients with chronic plaque psoriasis anthralin therapy was used as high-strength short-contact therapy in a bilateral comparison of anthralin versus 5% crude coal tar-anthralin combination. These two trials were undertaken with and witho …
In 44 patients with chronic plaque psoriasis anthralin therapy was used as high-strength short-contact therap
Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
Remitz A. Remitz A. Acta Derm Venereol. 1989;69(4):351-4. Acta Derm Venereol. 1989. PMID: 2568062
Previous studies have shown that when butantrone and dithranol were used in equimolar gradually increasing concentrations in short-contact therapy for psoriasis the efficacy of butantrone was somewhat lower compared to dithranol. To see whether the eff …
Previous studies have shown that when butantrone and dithranol were used in equimolar gradually increasing concentrations in short- …
Short-contact therapy.
Schaefer H. Schaefer H. Arch Dermatol. 1985 Dec;121(12):1505-9. Arch Dermatol. 1985. PMID: 4062330 No abstract available.
Anthralin cream as short contact therapy for psoriasis.
Miller AC. Miller AC. Cutis. 1985 Jun;35(6):578-82. Cutis. 1985. PMID: 4017653
We report a four-week study of twenty patients using an anthralin cream for thirty-minute short-contact therapy. Both 0.5 percent and 1.0 percent anthralin concentrations were evaluated. We found that short contact therapy with the anthra …
We report a four-week study of twenty patients using an anthralin cream for thirty-minute short-contact therapy. Both 0 …
Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
Göransson AM, Kolari PJ, Mustakallio KK. Göransson AM, et al. Acta Derm Venereol. 1984;64(2):134-9. Acta Derm Venereol. 1984. PMID: 6203301
Dithranol (D) and butantrone (BD) were compared as regards irritation and staining in conditions resembling short-contact therapy. ...After 3 h contact, it caused only minimal staining and markedly less irritation than equimolar D....
Dithranol (D) and butantrone (BD) were compared as regards irritation and staining in conditions resembling short-contact t
29 results
Jump to page
Feedback